Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

Preliminary Program: WEDNESDAY MAY 24

Industry-Supported Breakfast Symposia

IS39. Emerging Evidence in the Treatment of Bipolar Depression (Part 1) Supported by AstraZeneca Pharmaceuticals

1. The Clinical Management of Bipolar Disorder Frederick K. Goodwin, M.D.
   
2. How Guidelines Influence Acute and Long-Term Treatment of Bipolar Depression Robert M.A. Hirschfeld, M.D.
   
3. Treatment of Alcohol and Drug Abuse in Bipolar Disorder Kathleen T. Brady, M.D.
   

IS40. Bipolar Illness: The Road to Remission (Part 1) Supported by Bristol-Myers Squibb Co.

1. Is Remission Achievable in Bipolar Disorder? John L. Beyer, M.D.
   
2. Roadblocks to Remission in the Bipolar Patient Prakash S. Masand, M.D.
   

IS41. New Frontiers in Depression: Providing Solutions to Unmet Needs (Part 1) Supported by Solvay Wyeth Pharmaceuticals

1. Genetic Mechanisms of Mood and Temperament Daniel R. Weinberger, M.D.
   
2. Chronic Pain and Major Depression Alan F. Schatzberg, M.D.
   

IS42. What the Psychiatrist Needs to Know About Sleep-Related Movement Disorders (Part 1) Supported by GlaxoSmithKline

1. Diagnosis, Epidemiology, and Natural History of Restless Legs Syndrome and Periodic Limb Movements of Sleep Philip M. Becker, M.D.
   
2. Sleep, Health, and Quality of Life Consequences R. Robert Auger, M.D.
   
3. Diagnostic Challenges and Initial Treatment Strategies Cynthia L. Comella, M.D.
   

7:30 a.m.-5 p.m.

Registration/Course Enrollment Open

8 a.m.-12 p.m.

CME Courses 79-84

9 a.m.-10:30 a.m.

Clinical Case Conferences
4. Crossing the Line: Determining Your Patient Is Too Dangerous to Drive Carl B. Greiner, M.D., Laura W. Roberts, M.D., Steven P. Wengel, M.D., Nicole F. Wolfe, M.D. (for APA members only)

Discussion Groups
19. Marc Galanter, M.D., on How to Retain Addicted Patients in Ongoing Ambulatory Therapy

20. Marcia Goin, M.D., on Borderline Personality Disorder: Talking With Patients About Their Illness "What Do You Say?"

Lectures
L20. Psychiatry and Aging: Contributions of the International Medical Graduates Dilip V. Jeste, M.D., APA's George Tarjan Award Lecture

L21. Combining Neuroimaging and Pharmacology to Better Treat Alcoholism Karl Mann, M.D., International Lecture Series, Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

L22. Psychiatry and Education: When the Twain Meet James Comer, M.D.

Master Educator Clinical Consultations
13. James L. Griffith, M.D., Christina Puchalski, M.D., on The Role of Spirituality in the Care of Patients

14. Robert P. Cabaj, M.D., on Sexual Orientation and Gender Identity in Clinical Care

15. Helga Hannesdottir, M.D., on Doing a Residency Training in Psychiatry in the U.S. and Returning Home to Practice

Roundtable
Child and Adolescent Bipolar Disorder: Out of a Diagnostic Quandry Moderator: Richard E. D'Alli, M.D.

Component Workshops
CW37. Data Coupled With Advocacy Shaping Public Policy APA Illinois Psychiatric Society; Co-Chairpersons: Jagannathan Srinivasaraghavan, M.D., Daniel W. Hardy, M.D.

CW38. Disasters, Disparities, and Cultural Psychiatry APA/SAMHSA Minority Fellows Chairperson: Niranjan S. Karnik, M.D.

CW39. Doing More With Less: Challenges and Rewards of Becoming a Psychiatrist Executive APA Committee on Psychiatric Administration and Management; Chairperson: Sy A. Saeed, M.D.

CW40. Teaching the History of Psychiatry to Students and Residents: A Workshop Discussion on Content, Methods, and Ideals APA Corresponding Committee on History and Library; Chairperson: Avram H. Mack, M.D.

CW41. How to Be a More Creative Teacher: Winning Strategies for Residents and Faculty APA Council on Medical Education and Lifelong Learning; Co-Chairpersons: Joan M. Anzia, M.D., Lowell D. Tong, M.D.

CW42. The National Health Information Network and Psychiatry: How Will the Coming National Electronic Health Record Impact Our Patients and Our Practice? APA Corresponding Committee on Electronic Health Records; Chairperson: John J. Boronow, M.D.

CW43. Novel Careers in Psychiatry: Women Who Have Made Their Own Way APA Committee on Women; Co-Chairpersons: Marisa A. Giggie, M.D., Melva I. Green, M.D.

Issue Workshops
IW55. Supervising the Supervisors: See One, Do One, Teach One Model Shattered! An Innovative Group to Train Faculty to Teach Medical Students Co-Chairpersons: Joseph M. Garbely D.O., Javed A. Joy, M.D.

IW56. Psycho-Killers: Mental Illness and Homicide Chairperson: Renee M. Sorrentino, M.D.

IW57. Psychiatric Aspects of Deep Brain Stimulation for Parkinson's Disease Chairperson: Valerie Voon, M.D.

IW58. Dynamic Therapy With Self-Destructive Borderlines Co-Chairpersons: Eric M. Plakun, M.D., Edward R. Shapiro, M.D.

IW59. Training Psychiatric Residents in the Cognitive Therapy of Schizophrenia Chairperson: Page Burkholder, M.D.

IW60. The Mirror Has a Reflection: Teaching and Modeling Cultural Competency to General Psychiatry Residents Co-Chairpersons: Dionne A. Hart, M.D., Renato D. Alarçon, M.D.

IW61. Assisted Outpatient Treatment and Its Role in the Fabric of the Mental Health System Chairperson: Daniel Garza, M.D.

IW62. Psychiatrists in the Dean's Office: Career Opportunities and Career Development Chairperson: Carolyn B. Robinowitz, M.D.

IW63. Detection of Malingering; Chairperson: Alan R. Hirsch, M.D.

IW64. The Quality Information System: A New System for Measuring Progress in the Doctor-Patient Relationshi; Chairperson: Victor J. Buwalda, M.D.

IW65. Connection Is the Cure: Treating Relational Disorders Co-Chairpersons: Glenn N. Siegel, M.D., Mary Pittman, M.S.

9 a.m.-Noon

Media Workshops
MW4. I Used. I Am Sorry. Can I Come Back? "Sister Helen" Says: Piss Off APA Corresponding Committee on Treatment Services for Patients With Addictive Disorders; Co-Chairpersons: Petros Levounis, M.D., Marjorie E. Waldbaum, M.D.

MW5. The Movie "Fun" as a Framework for Exploring Conduct Disorder in Adolescent Girls Chairperson: Jessica C. Morgan, M.D.

MW6. Carter's Addiction: Substance Use Disorders in Physicians Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism; Chairperson: Christopher J. Welsh, M.D.

9 a.m.-12:30 p.m.

Advances in Mood Disorders David J. Kupfer, M.D.

Continuous Clinical Case Conference
1, Part 2. R. Rao Gogineni, M.D., Sheila Judge, M.D., Richard P. Kluft, M.D., Robert Michels, M.D., on 20 Therapies Later: Addressing Tranference Resistance (for APA members only)

9 a.m.-4 p.m.

CME Courses 85-91

10 a.m.-3 p.m.

Exhibits Open (last day)

APA Member Center Open (last day)

Publishers' Bookfair Open (last day)

11 a.m.-12:30 p.m.

Discussion Groups
21. Michelle B. Riba, M.D., on The Role of the Psychiatrist in End-of-Life Care

22. Patricia Ordorica, M.D., on The Future of Psychiatry: What the Resident Should Know (for residents only)

Lectures
L23. High on Neurosteroids: Mechanisms and Therapeutic Relevance A. Leslie Morrow, Ph.D., Frontiers of Science Lecture Series

L24. I Am All in Favor of Research But I Need Help Tomorrow or Next Week: The Plaint of a University President on the Firing Line of Leadership in an Alcohol-Saturated Peer Culture Edward Malloy, Ph.D., Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

L25. Medications That Act at Ion Channels as Treatment for Alcohol Dependence Bankole Johnson, M.D., Distinguished Psychiatrist Lecture Series, Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

Master Educator Clinical Consultations
16. David Baron, D.O., on Performance-Enhancing Drug Use in Adolescent Athletes: A Sports Psychiatry Perspective

17. Ellen Haller, M.D., on Working With Lesbian, Gay, Bisexual, and Transgendered Patients: What Do You Need to Know?

Toronto's Old Town neighborhood features historic sites dating to 1793.

Medical Update 3. Jerald Bain, M.D. on Testosterone Replacement Therapy in the Aging Male: Implications for Psychiatry and Other Disciplines

Research Consultation 3. Howard Goldman, M.D., on Mental Health Policy Research

Scientific and Clinical Reports
Session 23. Sleep Disorders
67. Effect of Armodafinil on Reducing Fatigue in Patients With Narcolepsy Russell Rosenberg, Ph.D.

68. Effect of Armodafinil on Attention in Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, and Shift Work Sleep Disorder Keith Wesnes, Ph.D.

69. Armodafinil Improves Wakefulness in Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, and Shift Work Sleep Disorder Milton Erman, M.D.

Session 24. ECT
70. Predictors of Referral for ECT Bonnie L. Szarek, R.N.

71. ECT Stimulus Dose as Physiological Volume of Seizure Foci Conrad M. Swartz, M.D.

72. The Efficacy and Outcome of Combining ECT and Atypical Antipsychotics for Treatment-Resistant Depression Randall T. Espinoza, M.D.

Session 25. Health, Nutrition, and Weight in Schizophrenia
73. Assessing Health and Nutrition Status of Urban Psychiatric Outpatients David J. Hellerstein, M.D.

74. Are Females at Special Risk for Obesity if They Become Psychotic? The Longitudinal Northern Finland 1966 Birth Cohort Study Hannu J. Koponen, M.D.

75. A 12-Week Open-Label Trial of Topiramate for Limiting Weight Gain During Olanzapine Treatment in Patients With Schizophrenia Jin-Hun Kim

Session 26. Developmental Issues in Schizophrenia
76. Altered Developmental Trajectories in Schizophrenia Matti K. Isohanni, Dr. Med. Sc.

77. Characteristics of the Interpersonal Distance of Patients With Schizophrenia in the Virtual Environment Sung-Hyouk Park, M.D.

78. Familial Risk of Psychosis and Prodromal Features of Psychosis at the Age of 15-16 Years Juha M. Veijola, M.D.

Session 27. Treatment of Schizophrenia
79. An Effectiveness Trial of a Brief Cognitive-Behavioral Intervention by Mental Health Nurses in Schizophrenia: Clinically Important Outcomes in the Medium Term Shanaya Rathod, M.D.

80. Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of First-Episode Psychosis: A Randomized, Double-Blind, 52-Week Comparison Joseph P. McEvoy, M.D.

81. Quetiapine for Bipolar Disorder and Schizophrenia: Appropriate Dose for Optimal Response Arthur L. Lazarus, M.D.

Session 28. Recent Research on SSRIs
82. Early Symptomatic Worsening During Treatment With Fluoxetine in MDD: A Replication Study Cristina Cusin, M.D.

83. Meta-Analysis of Efficacy of Paroxetine Versus Placebo Utilizing the GlaxoSmithKline Clinical Trials Registry Lawrence W. Adler, M.D.

84. Resolution of Sleepiness and Fatigue in the Treatment of MDD: A Comparison of Bupropion and SSRIs George I. Papakostas, M.D.

Session 29. Epidemiological Studies of Adverse Events in Institutionalized Populations
85. Death by Unnatural Causes During Childhood and Early Adulthood in Offspring of Psychiatric Inpatients Roger T. Webb, M.S.C.

86. The Incidence and Prevalence of Diabetes Mellitus Among Inpatients in State-Operated Psychiatric Hospitals in New York State 1997-2004 Leslie L. Citrome, M.D.

87. Associations Between Psychiatric Disorder and Commitment Criteria in Acute Involuntarily Admitted Patients in the Netherlands Cornelis Mulder, M.D.

Session 30. Treatment of Adverse Events
88. PDE5I Sildenafil Treatment of Serotonergic Antidepressant Associated Sexual Dysfunction in Women With MDD in Remission: An Eight-Week Randomized, Double-Blind, Placebo-Controlled Trial With Eight-Week Open-Label Continuation H. George Nurnberg, M.D.

89. Theoretical Implications of Improved Depression Severity by PDE5I Sildenafil Treatment of Erectile Dysfunction Associated With Treated or Untreated MDD for Endothelial Dysfunction Mediation Richard L. Siegel, M.D.

90. Efficacy of Sildenafil for the Treatment of Erectile Dysfunction in Men Taking Antidepressant Medication: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies Joseph C. Cappelleri, Ph.D.

Session 31. BPD
91. Structural Brain Abnormalities in BPD Paul H. Soloff, M.D.

92. Neurobiological Correlates of Diagnosis and Underlying Traits in Patients With BPD Compared With Normal Controls Joel F. Paris, M.D.

93. BPD and Suicide Attempt: Are There Any Correlates Between Attempters and Non-Attempters? Tavi Thongdy, M.D.

Session 32. Women's Health Issues
94. Gender Differences in Schizophrenia and Other Psychotic Disorders: A 20-Year Follow-Up Study Linda S. Grossman, Ph.D.

95. Severe Personality Disorders in the Offspring of Antenatally Depressed Mothers: A 31-Year Follow-Up of the Northern Finland 1966 Birth Cohort Pirjo H. Maki, M.D.

96. Outcome of Prenatal Anxiety, Stress, and Depression Gisèle Apter-Danon, M.D.

Session 33. Cross-Cultural and Minority Issues
97. All Equal? Advocating Equity in Mental Health Services in France to Ethnic-Minority Disadvantaged Youth and Their Families Through Evidence-Based Protocols Leon-Patrice Celestin, M.D.

98. Stories About Mental Health: A Cross-Cultural Relapse-Prevention Study in Northern Territory Aboriginal Communities Tricia M. Nagel

99. Recognizing and Engaging Depressed Chinese Americans in Treatment in a Primary Care Setting Albert Yeung, M.D.

Component Workshop
CW44. Global Psychiatry: Establishing Formal and Informal Mental Health Exchanges APA Council on Global Psychiatry; Co-Chairpersons: Samuel O. Okpaku, M.D., William Lawson, M.D.

CW45. School-Based Suicide Prevention: Evidence-Based Strategies and New Approaches APA Corresponding Committee on Mental Health and Schools; Co-Chairpersons: Eugenio M. Rothe, M.D., Daniel Castellanos, M.D.

CW46. A Research Agenda for DSM-V: Mental Health in the Gay, Lesbian, and Bisexual Populations APA Committee on Gay, Lesbian, and Bisexual Issues; Co-Chairpersons: Benjamin H. McCommon, M.D., Jack Drescher, M.D.

CW47. Welcome to the Jungle: The Dynamics Between Residents and Industry APA/GlaxoSmithKline Fellows; Co-Chairpersons: Lisa A. Catapano, M.D., Itai Danovitch, M.D.

CW48. Trauma of Hearts and Minds: Racism and Psychiatry in the 21st Century APA/SAMHSA and APA/AstraZeneca Minority Fellowships; Co-Chairpersons: Napoleon B. Higgins Jr., M.D., Jean-Marie E. Alves-Bradford, M.D.

CW49. Current Issues in Psychiatry and Law APA Council on Psychiatry and Law; Chairperson: Paul S. Appelbaum, M.D.

Issue Workshops
IW66. Psychiatry Training for Primary Care Physicians: An Ongoing Challenge Chairperson: Hoyle Leigh, M.D.

IW67. When Therapeutic Lifestyle Changes Fail: Pharmacologic Management of Metabolic Syndrome in Psychiatry Co-Chairpersons: Peter Manu, M.D., Raymond E. Suarez, M.D.

IW68. Countertransference and Boundary Issues of Residents Treating Medical Students, Fellow Residents, and Attendings Chairperson: Benjamin D. Lederer, M.D.

IW69. Applying for National Institute of Alcohol Abuse and Alcoholism Research Money: Some Things You Didn't Learn in Graduate School Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism; Chairperson: Robert Huebner, Ph.D.

IW70. The Nature of Nurture: The Long-Lasting Impacts of Early Adverse Life Events Co-Chairpersons: Mireya Nadal-Vicens, M.D., Stacy S. Drury, M.D.

IW71. Maintenance of Certification for Diplomates of the American Board of Psychiatry and Neurology Chairperson: Stephen C. Scheiber, M.D.

IW72. Responding to the Impact of Suicide on Clinicians Chairperson: Eric M. Plakun, M.D.

IW73. Non-Governmental Organizations: Response to Mental Health Consequences of Asian Tsunami Chairperson: Jagannathan Srinivasaraghavan, M.D.

IW74. Approaches to Chronic Disease Management: Opportunities for Psychiatry Chairperson: Nick Kates, M.B.

IW75. The Key to Success, Mentorship Matters: A Practical Guide for Trainees and Educators Chairperson: Anita R. Kishore, M.D.

IW76. The Evolution of Grandfamilies: The Psychological, Social, and Financial Impact of Grandparents Raising Grandchildren American Academy of Child and Adolescent Psychiatry; Co-Chairpersons: James E. Lee Jr., M.D., Sandra C. Walker, M.D.

Noon-1:30 p.m.

Forums
10. Correctional Mental Health Issues: An International Perspective Chairperson: Jeffrey L. Metzner, M.D.

11. Katrina: Psychiatric Responses and Care for Individuals and Communities Chairperson: Robert J. Ursano, M.D.

12. Addressing Psychiatric Needs in Asia APA Council on Global Psychiatry; Chairperson: Pedro Ruiz, M.D.

13. Environmental Psychiatry: From Sick Buildings to the Gulf War Chairperson: Claudia S. Miller, M.D.

Noon-2 p.m.

New Research Poster Session 8

1 p.m.-5 p.m.

CME Courses 92-97

2 p.m.-3:30 p.m.

Lecture
L26. Beyond Dopamine: Neuroadaptations, Negative Affect, and Clinically Relevant Treatment Targets in Alcoholism, Markus Heilig, M.D., Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

2 p.m.-5 p.m.

Presidential Symposia
3. Collaboration in Crisis: Academic Medical Centers' Response to Hurricanes Katrina and Rita Chairperson: Joseph D. Hamilton, M.D.

4. Psychiatric Participation in Interrogation of Detainees: Ethical Considerations Chairperson: Steven S. Sharfstein, M.D.

Symposia
S66. Risk Factors, Personality Variables, and Addictive Disorders Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

1. Risk Factors for Addictive Disorders Maurice Corcos, Ph.D.
   
2. Dependency and Suicidality in Addictive Disorders Gwenole Loas, M.D.
   
3. Depressive Psychopathology in Addictive Disorders Mario Speranza, M.D.
   
4. Sensation Seeking and Addictive Disorders Alexandra Pham-Scottez
   
5. Addictive Disorder: Goodman's Concept of Addiction: A Study of 692 Addictive Subjects Ludovic A. Gicquel, Ph.D.
   

S67. Reductionism in Psychiatry: Implications and Limits Association for the Advancement of Philosophy and Psychiatry

1. Is Modern Biological Psychiatry Reductionistic or Integrative? G. Scott Waterman, M.D.
   
2. Dr. Chekhov and the Multiplicity of Psychiatric Experience Bradley E. Lewis
   
3. Reduction in Psychiatry Ian Gold, Ph.D.
   
4. Reducing Reductionism: Reclaiming Psychiatry Wesley E. Sowers, M.D.
   

S68. Complex PTSD Across the Lifespan: Implications for DSM-V

1. Disorders of Extreme Stress: Results from the DSM-IV Field Trial Bessel A. Van Der Kolk, M.D.
   
2. Self-Regulation as a Framework for Conceptualizing and Treating Complex PTSD Julian Ford, Ph.D.
   
3. Early Childhood Trauma, Insecure Attachment, and Complex PTSD Marylene Cloitre, Ph.D.
   

S69. Pharmaceutical Industry Influence in Psychiatry

1. Physicians and Industry: A Review of Commercial Influence on Medical Decision Making Jerome P. Kassirer, M.D.
   
2. Psychiatric CMEs and Commercial Bias: Are New ACCME Standards Effective? Daniel J. Carlat, M.D.
   
3. The ADHD/Psychostimulant Epidemic: The Role of the Pharmaceutical Industry Lawrence H. Diller, M.D.
   
4. Relationship Between Drug Company Funding and Outcomes of Clinical Psychiatric Research Robert E. Kelly Jr., M.D.
   
5. Psychiatric Research as Marketing: Common Distortions of Research Design in Industry-Sponsored Clinical Trials Daniel J. Safer, M.D.
   

S70. New Directions in Community Psychiatry

1. Poverty Reduction Strategies: An Important Focus for Early Intervention Programs Terry Krupa, Ph.D.
   
2. Aiming for the Stars: Refining Recovery in Practice Helen M. Glover, B.S.W.
   
3. You Can Do It. We Can Help Larry Davidson, Ph.D.
   

S71. How to Practice Evidence-Based Medicine

1. Introduction to Evidence-Based Medicine Kumaraswamy Budur, M.D.
   
2. Review of Basic Statistical Concepts Maju Mathews, M.D.
   
3. Critical Appraisal of Systematic Reviews and Meta-Analysis Babatunde A. Adetunji, M.D.
   
4. Critical Appraisal of Randomized, Controlled Studies Adedapo B. Williams, M.D.
   

S72. The Problem of Outcomes With the Difficult-to-Treat Patient

1. Framing the Problem of Outcome With the Difficult-to-Treat Patient Richard L. Munich, M.D.
   
2. Rethinking Outcomes in Mentalization-Based Treatment Jon G. Allen, Ph.D.
   
3. Cognitive-Behavioral Therapy for Treatment Refractory OCD and Other Anxiety Disorders: Outcome Data From a Specialized Hospital Program Throstur Bjorgvinsson, Ph.D.
   
4. The Problem of Outcomes With the Difficult-to-Treat Patient Norma V. Clarke, M.D.
   
5. Future Direction of Specialized Treatment Programs: Mentalizing, Brain Imaging Studies, and Preliminary Outcomes Efrain Bleiberg, M.D.
   

S73. The Art and Science of Brief Psychotherapies

1. Brief Cognitive Therapy Judith S. Beck, Ph.D.
   
2. Interpersonal Psychotherapy Scott P. Stuart, M.D.
   
3. Solution-Focused Brief Therapy Brett Steenbarger
   
4. Common Factors: Essential Ingredients for Successful Psychotherapy Roger P. Greenberg
   

S74. Neuropsychiatric Responses to Burns: Modeling the Developmental Neurobiology of Trauma

1. Neurobiological Responses to Burn Trauma John B. Levine, M.D.
   
2. The Psychology and Physiology of Burn Stress in Very Early Childhood Jennifer E. Drake, M.A.
   
3. Determinants of Traumatic Stress in Older Children Glenn Saxe, M.D.
   
4. Pharmacological and Psychological Prevention of PTSD Rohini Luthra, Ph.D.
   
5. Psychopharmacological Interventions for Stress in Children Frederick J. Stoddard Jr., M.D.
   

S75. Acute Brief Psychoses: Nosology and Boundaries

1. Acute and Transient Psychotic Disorders Prof. Andreas Marneros
   
2. The Relationship Between Acute and Transient Psychotic Syndromes and Psychotic Symptoms in the General Population: Implications for Causes and Treatment Peter B. Jones, Dr. Med. Sc.
   
3. Panic Attacks With Psychotic Features: A Variant of Nonaffective Acute Remitting Psychoses? Igor I. Galynker, M.D.
   
4. The Place of Nonaffective Acute Remitting Psychoses in DSM-IV and ICD-10 Ramin Mojtabai, M.D.
   

S76. Enhancing the Well-Being of Older Persons With Schizophrenia APA Council on Aging

1. Assessing Medical Comorbidity and Optimizing Medical Care in Older Patients With Schizophrenia Ipsit Vahia, M.D.
   
2. Enhancing Quality of Life in Older Persons With Schizophrenia Azziza O. Bankole, M.D.
   
3. Diminishing Depression in Older Adults With Schizophrenia: Targets for Intervention Shilpa P. Diwan, M.D.
   
4. Adaptive Functioning in Older Persons With Schizophrenia Carl I. Cohen, M.D.
   

S77. Demoralization and Psychotherapy: A Tribute to Jerome D. Frank, M.D.

1. The Demoralization Hypothesis: Conceptualization, Epidemiology, and Clinical Relevance John M. de Figueiredo, M.D.
   
2. Demoralization in the Experience of Being Ill David Clarke
   
3. Brief Psychotherapy at the Bedside: Countering Demoralization From Medical Illness James L. Griffith, M.D.
   

S78. Use of Quantitative Instruments for Monitoring Depression Severity: Clinical Applications

1. National Depression Management Leadership Initiative: Improving Depression Care Henry Chung, M.D.
   
2. Depression Management Experience in Private Versus Public Psychiatric Practices Rodrigo A. Muñoz, M.D.
   
3. Depression Management Experience in Primary Care Jack S. McIntyre, M.D.
   
4. Depression Screeening and Management in New York City Lloyd I. Sederer, M.D.
   
5. Optimizing the Treatment of Depression: Using Treatment Algorithms in Conjunction With Standardized Instruments in Clinical Care Settings Madhukar H. Trivedi, M.D.
   

S79. Women's Life Cycle and Mental Health

1. The Female Life Cycle: From Childhood to Old Age G. William Bates, M.D.
   
2. Menopausal Management Esther Eisenberg, M.D.
   
3. TBD Patricia Matthews-Juarez, Ph.D.
   
4. Psychosocial Aspects of Infertility Samuel O. Okpaku, M.D.
   

S80. Stalking Offenders and Victims

1. Stalking: An Overview of the Problem Gail E. Robinson, M.D.
   
2. Stalking Victims: A Comprehensive Treatment Approach Karen M. Abrams, M.D.
   
3. Stalking: A Treatment Concept for Offenders Werner Tschan, M.D.
   

S81. Nicotine Dependence and Schizophrenia: Neurobehavioral Pathways National Institute on Drug Abuse

1. Nicotine Intake and Blood Levels in Smokers With Schizophrenia Jill Williams, M.D.
   
2. Effects of Biological and Environmental Challenges on Smoking in Schizophrenic Versus Nonpsychiatric Heavy Smokers Jennifer W. Tidey, Ph.D.
   
3. Nicotine Abuse and the Neurobiology of Schizophrenia Robert Freedman, M.D.
   
4. Pharmacological Treatment of Nicotine Dependence in Schizophrenia: Modulation of Outcomes by Atypical Antipsychotic Drugs, Cognitive Function, and Genetic Polymorphisms Tony P. George, M.D.
   
5. Integrating Tobacco Dependence Treatment Into Mental Health Treatment Douglas M. Ziedonis, M.D.
   

S82. Adolescent Alcohol Use Disorders and Psychiatric Comorbidity Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

1. Trauma and Alcohol Use Disorders in Adolescents: Psychiatric Comorbidity and Adult Outcomes Duncan B. Clark, M.D.
   
2. Assessing Alcohol Problems in Adolescents With Psychiatric Comorbidity Deborah Deas, M.D.
   
3. Treatment of Adolescents With Alcohol Problems and Major Depression Jack R. Cornelius, M.D.
   
4. When ADHD and Substance Use Disorders Collide Timothy E. Wilens, M.D.
   

S83. Educating a New Generation of Physicians in Psychiatry: Focus on Medical Student Education

1. Medical Student Education in Psychiatry: Where We Are and Where We Can Go Myrl R.S. Manley, M.D.
   
2. Medical Student Education in Psychiatry: A Model Lowell D. Tong, M.D.
   
3. Medical Student Education in Psychiatry: Impacting Career Choice and Practice Brian A. Palmer, M.D.
   
4. Medical Student Education in Psychiatry: What We Can Learn From Other Disciplines Deborah Danoff, M.D.
   

S84. Patient Safety: To Err Is Human, To Be Safe Is Divine APA Committee on Patient Safety

1. Length of Stay in the Psychiatric Emergency Room of an Urban Teaching Hospital Patrick T. Triplett, M.D.
   
2. A Primer for Prescribing: How to Prevent Medication Errors Kathryn J. Ednie, M.D.
   
3. Educating Faculty and Residents on Patient Safety Carl B. Greiner, M.D.
   
4. Suicide and Patient Safety Geetha Jayaram, M.D.
   
5. Your Role and All of Our Roles in Making Patient Safety a Bigger Reality Alfred Herzog, M.D.
   

S85. Relationships Between Axis I and Axis II Association for Research in Personality Disorders

1. State and Trait in Personality Disorders James H. Reich, M.D.
   
2. Spectra of Pathology Across Axis I and Axis II Disorders David P. Bernstein, Ph.D.
   
3. Etiological Relationships Among Dimensions of Personality Disorders and Axis I Syndromes John Livesley, M.D.
   
4. A Comparison of Mu-Opioid Receptor Activity in Depressed Subjects and in Subjects With Borderline Personality Disorder Kenneth R. Silk, M.D.
   
5. A Neurobiologic Perspective on the Relationship Between Axis I and Axis II Disorders Larry J. Siever, M.D.
   

S86. Science to Policy: Advancing Women's Mental Health Association of Women Psychiatrists

1. Science to Policy: Psychiatric Aspects of Reproductive Health Nada L. Stotland, M.D.
   
2. PTSD in Women Veterans: From Science to Policy Marian I. Butterfield, M.D.
   
3. Premenstrual Dysphoric Disorder: Treatment Update Tana A. Grady-Weliky, M.D.
   
4. Neuroactive Steroids in Men and Women: Investigations in Schizophrenia, Bipolar Disorder, and Alzheimer's Disease Christine E. Marx, M.D.
   
5. Ethnic and Racial Disparities in Women's Mental Health Annelle B. Primm, M.D.
   

S87. Alcohol, Drugs, and Psychiatric Disorders in the U.S. Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

1. Comorbidity of Pain and Substance Use Disorders in the U.S. Wilson M. Compton, M.D.
   
2. Antisocial Personality Disorder and Lifetime Course of Alcohol Use Disorders in the U.S. General Population Rise B. Goldstein, Ph.D.
   
3. Prevalence, Correlates, and Comorbidity of Alcohol Use Disorders in the U.S. Frederick S. Stinson, Ph.D.
   
4. Prevalence, Correlates, and Comorbidity of Nonmedical Sedative, Tranquilizer, Opioid, and Amphetamine Use, Abuse, and Dependence in the U.S. Bridget F. Grant, Ph.D.
   
5. Cannabis Withdrawal Syndrome in 2,613 Lifetime Heavy Cannabis Users From a National Survey: Symptom Prevalence, Factor Structure, and Correlates Deborah S. Hasin, Ph.D.
   

S88. Sobering Facts: Alcohol Dependence and Treatment Interventions Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

1. The Impact of Alcohol Use Disorders Richard J. Frances, M.D.
   
2. Alcohol Dependence: Difficulties in Diagnosis Kathleen T. Brady, M.D.
   
3. Integrating Pharmacotherapy and Psychosocial Support in Treating the Alcohol-Dependent Patient Roger D. Weiss, M.D.
   
4. Pharmacotherapy for the Treatment of Alcohol Dependence: Review of Outcome Data Robert M. Swift, M.D.
   

S89. Pharmacotherapy for Single- and Dual-Diagnosed Substance Abusers American Academy of Addiction Psychiatry

1. Comorbidity With Opioid Dependence Edward V. Nunes, M.D.
   
2. Pharmacotherapy of Comorbid Substance Abuse and Schizophrenia Steven L. Batki, M.D.
   
3. Comorbidity of General Psychiatric Disorders and Cocaine Abuse Thomas R. Kosten, M.D.
   
4. The Comorbidity of Bipolar Spectrum Disorders and Substance Use Disorders Stephen Ross
   

S90. Science and Regulation Affecting Private Practice

1. Evidence-Based Medicine in Child and Adolescent Psychiatry: What Is Your Best Guess? Jeffrey A. Naser, M.D.
   
2. Evidence-Based Medicine in Solo Private Practice: What If the Patient Doesn't Fit? Ronald D. Abramson, M.D.
   
3. Missing Resources: Comprehensive Psychiatry for People With Medical Illnesses John C. Urbaitis, M.D.
   
4. Comprehensive Psychiatry in 2006: Confidentiality and Access to Care in Private Practice and in Military Practice Brian Crowley, M.D.
   
5. TBD Harold I. Eist, M.D.
   

S91. Recent Advances in Ethnopsychopharmacological, Ethnic, and Cultural Aspects of Mood and Anxiety Disorders

1. Ethnopsychopharmacology David C. Henderson, M.D.
   
2. Psychiatric Management of Hispanic Patients: Cross-Cultural Issues and Ethnopsychopharmacology David Mischoulon, M.D.
   
3. Impact of Cultural Beliefs on the Treatment of Depressed Chinese Americans Albert Yeung, M.D.
   
4. Challenges in the Diagnosis and Treatment of Mood and Anxiety Disorders in the Asian-Indian Population: Cross-Cultural Factors and Psychopharmacological Considerations Rajesh M. Parikh, M.D.
   

S92. Anxiety and Emotional Dysfunction in Endophenotype of Schizophrenia

1. Schizophrenia and Obsessive-Compulsive Disorder: The Role of Serotonergic and Dopaminergic Systems Joseph Zohar
   
2. Anxiety Comorbidities and Role of Emotion in Endophenotype of Schizophrenia Stefano Pallanti
   
3. Investigating the Cognitive and Emotional Neuropsychology of Schizophrenia Comorbid With Anxiety Disorders Naomi A. Fineberg, M.A.
   
4. Psychophysiological Investigation of Pathological Anxiety and Emotional Dysfunction in Patients With Schizphrenia Werner Strik, M.D.
   

S93. Teaching Psychiatry Residents About Informed Consent

1. Informed Consent in Psychiatry: An Overview Thomas G. Gutheil, M.D.
   
2. Initiation of Psychotherapeutic and Psychopharmacologic Treatment by Psychiatry Residents Bret R. Rutherford, M.D.
   
3. Informed Consent for Psychotherapy Thomas G. Gutheil, M.D.
   
4. Complications of the Informed-Consent Process in Psychotherapy Glen O. Gabbard, M.D.
   
5. Informed Consent in Psychopharmacology Steven K. Hoge, M.D.
   

S94. Sustained Recovery and Healthy Functioning: The Long and Short of It

1. Evidence for Recovery in the Psychotherapy of Personality Disorders John C. Perry, M.D.
   
2. Change in Psychological Risk and Recovery in Recurrent Depression Elisabeth Banon
   
3. Dynamic Recovery in Patients With Treatment-Refractory Disorders Christopher Fowler
   
4. Examining the Sequence of Recovery in Long-Term Dynamic Psychotherapy Michael P. Bond
   
5. A Review of Treatment Evidence on Sustained Recovery and Healthy Functioning Daniel Frank, M.D.
   

S95. Mental Health Disparities: Concepts, Assessment, Evidence-Based Practice, and Advocacy APA Council on Minority Mental Health and Health Disparities

1. Estimating Mental Health Disparities for Latinos and Asians Using the National Latino and Asian-American Study Margarita Alegria, Ph.D.
   
2. Strategies for Assessing Mental Health Disparities Using Health Care for Communities Thomas McGuire, Ph.D.
   
3. Addressing Mental Health Disparities in Evidence-Based Mental Health Practices Steve Leff
   
4. Reducing Mental Health Disparities for Racial and Ethnic Minorities: The APA Plan of Action Francis G. Lu, M.D.
   

S96. Fearful Sleep Arousals

1. Does Movement Suppression Index Central Fear System Involvement in PTSD Nightmares? Steve H. Woodward, Ph.D.
   
2. Sleep Terrors and Sleepwalking in Children and Adults Rosalind D. Cartwright, Ph.D.
   
3. Nocturnal Panic Attack: An Underrecognized Fearful Arousal Ravi K. Singareddy, M.D.
   
4. Sleep Paralysis: Overlooked Fearful Arousal Thomas W. Uhde, M.D.
   

S97. Translating the Neurobiology of Alcoholism Into Clinical Treatments Collaborative Session With the National Institute on Alcohol Abuse and Alcoholism

1. Lost in Translation: Preclinical Studies of Genetic Susceptibility and Neuroadaptations Point to a Growing List of Novel Candidate Targets for Treatment of Alcoholism Markus Heilig, M.D.
   
2. Medications for Treating Alcoholism: From Animal Models to Clinical Usefulness Charles P. O'Brien, M.D.
   
3. Animal Models for Novel Medications for Alcoholism: View From the Dark Side George F. Koob
   
4. Alcohol Relapse-Like Behavior in Laboratory Animals: The Nociceptin/Orphanin Fq System: A Potential Target for the Development of New Pharmacotreatments Roberto Ciccocioppo, Ph.D.
   
5. TBD Barbara J. Mason, Ph.D.
   

S98. Same-Sex Civil Marriage: Historical and Mental Health Research Perspectives

1. Gay Marriage in History: New Manifestations of Old Traditions Robert P. Cabaj, M.D.
   
2. Gay Marriage in The Netherlands: The First Five Years Nicolaas F. Hettinga, M.D.
   
3. Leading the Way: Canadian Same-Sex Marriage Laura M. Chapman, M.D.
   
4. Six Weeks of Marriage Vows in San Francisco: Personal Perspectives Ellen Haller, M.D.
   
5. Same-Sex Marriage From a Mental Health Research Perspective Robert M. Kertzner, M.D.
   

S99. Psychiatry in Amsterdam: Acute Psychiatric Services in a Metropolitan Area

1. The Amsterdam Model: Past, Present, and Future Hans Sanders, M.D.
   
2. Urbanization as a Risk Indicator for Psychiatric Disturbances Jack J. Dekker, Ph.D.
   
3. A One-Year Prospective Study of the Temporary Transitional Unit Wijnand Mulder, M.D.
   
4. Controversies and Dilemmas Regarding the Amsterdam Model: Case Histories Hans Nusselder, M.D.
   
5. Community Admission Units in Amsterdam: A Benchmark Study Cecilia Gijsbers Van Wijk, M.D.
   

2 p.m.-5:30 p.m.

Advances in Schizophrenia Jeffrey Lieberman, M.D.

3 p.m.-5 p.m.

New Research Poster Session 9

7 p.m.-10 p.m.

Industry-Supported Symposia IS43. What Is the Role of Somatic and Physical Symptoms in Depression? Supported by Wyeth Pharmaceuticals

1. The Neurobiology of Somatic and Physical Symptoms in Depression Pedro L Delgado, M.D.
   
2. Pain and Other Somatic Symptoms and Their Relationship to Antidepressant Treatment Outcome George I. Papakostas, M.D.
   
3. Diagnostic Challenges in Medically Ill Patients With Depression Donna E. Stewart, M.D.
   
4. Management Issues in the Treatment of Depression With Comorbid Medical Disorders Jonathan E. Alpert, M.D.
   
5. Are All Antidepressants Equally Effective in the Treatment of Somatic and Physical Symptoms in Depression? Maurizio Fava, M.D.
   

IS44. Diagnosing and Treating Alcohol Dependence in the Office Supported by Alkermes Inc. and Cephalon Inc.

1. Alcoholism as a Chronic Disease: Implications for Office-Based Treatment A. Thomas McLellan, Ph.D.
   
2. Screening, Diagnosis, and Early Intervention Kathleen T. Brady, M.D.
   
3. Current and Emerging Treatment Options in Alcoholism Richard N. Rosenthal, M.D.
   
4. Office-Based Treatment of Co-Occurring Psychiatric Disorders Shelly F. Greenfield, M.D.
   
5. Behavioral Therapies for Alcohol Dependence Grace Hennesy, M.D.
   

IS45. Managing Unmet Needs in Psychiatric Illnesses: A Critical Look at Disorders and Public Policy Supported by Solvay Wyeth Pharmaceuticals

1. Managing the Unmet Needs in Depression A. John Rush, M.D.
   
2. Managing the Unmet Needs in Bipolar Disorder Roger S. McIntyre, M.D.
   
3. Managing the Unmet Needs in Schizophrenia Marvin S. Swartz, M.D.
   
4. Managing the Unmet Needs in Dementia K. Ranga R. Krishnan M.B.
   
5. Managing the Unmet Needs: A Public Health Dilemma Junius J. Gonzales, M.D.
   

IS46. Remission and Recovery in Schizophrenia: Advocating for Our Patients Supported by Eisai Inc. and Pfizer Inc.

1. Defining Remission and Recovery in Schizophrenia Nancy C. Andreasen, M.D.
   
2. Should Functional Outcomes Be a Defining Feature of Remission and Recovery in Schizophrenia? Stephen R. Marder, M.D.
   
3. An Evidence-Based Approach to Achieving Remission and Recovery in Schizophrenia John M. Kane, M.D.
   
4. Barriers to Achieving Remission and Recovery in Schizophrenia Meera Narasimhan, M.D.
   

Email this article to a Colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles via Google Scholar Search for Related Content

Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us